{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:03:27Z","timestamp":1778123007149,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.urology.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T19:13:30Z","timestamp":1546974810000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Medical Treatments of Peyronie's Disease: Past, Present, and Future"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6138-2255","authenticated-orcid":false,"given":"Daan C.J.","family":"Mohede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igle Jan","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mels F.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2019.01.001_bib0001","series-title":"Classical writings on erectile dysfunction An annotated collection of original texts from three millennia","first-page":"105","article-title":"Fran\u00e7ois Gigot de la Peyronie: the first complete clinical description of induration penis plastic","author":"Hauck","year":"2005"},{"key":"10.1016\/j.urology.2019.01.001_bib0002","first-page":"318","article-title":"Sur quelques obstacles qui s'opposent \u00e0 l\u2019\u00e9jaculation naturelle de la semence","volume":"1","author":"De la Peyronie","year":"1743","journal-title":"M\u00e9m Acad Roy Chir"},{"key":"10.1016\/j.urology.2019.01.001_bib0003","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.eururo.2006.10.048","article-title":"Seeking answers on the quest for effective nonsurgical treatment of Peyronie's disease","volume":"51","author":"Levine","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0004","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1464-410X.2004.04587.x","article-title":"The management of Peyronie's disease","volume":"93","author":"Ralph","year":"2004","journal-title":"Br J Urol Int"},{"key":"10.1016\/j.urology.2019.01.001_bib0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0006","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's Disease: AUA Guideline","volume":"3","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0007","first-page":"222","article-title":"Des H\u00f4pitaux","volume":"19","author":"Ricord","year":"1840","journal-title":"Bull Gen Ther Paris"},{"key":"10.1016\/j.urology.2019.01.001_bib0008","series-title":"Textbook, dis G-U Org, Arch F Dermat Syph","first-page":"572","article-title":"1875","author":"Van Buren","year":"1874"},{"key":"10.1016\/j.urology.2019.01.001_bib0009","first-page":"31","article-title":"No Title","volume":"28","author":"Hodgen","year":"1876","journal-title":"Trans Med Soc, Missouri"},{"key":"10.1016\/j.urology.2019.01.001_bib0010","series-title":"Diseases of the testis, spermatic cord and scrotum","first-page":"460","article-title":"Impotency","author":"Curling","year":"1878"},{"key":"10.1016\/j.urology.2019.01.001_bib0011","article-title":"No Title","volume":"181","author":"Dubuc","year":"1890","journal-title":"Ann Des Mal Des Orgn G-U"},{"key":"10.1016\/j.urology.2019.01.001_bib0012","first-page":"38","article-title":"No Title","volume":"14","author":"O'Zoux","year":"1896","journal-title":"Ann Des Mal Des Orgn G-U"},{"key":"10.1016\/j.urology.2019.01.001_bib0013","first-page":"111","article-title":"No Title","volume":"14","author":"Sachs","year":"1901","journal-title":"Wien Klin Woch"},{"key":"10.1016\/j.urology.2019.01.001_bib0014","series-title":"Surgery: its theory and practice","first-page":"1037","article-title":"Sores on the penis","author":"Walsham","year":"1903"},{"key":"10.1016\/j.urology.2019.01.001_bib0015","article-title":"No Title","volume":"181","author":"Reliquet","year":"1890","journal-title":"Ann Des mal Des Orgn G-U"},{"key":"10.1016\/j.urology.2019.01.001_bib0016","first-page":"1427","article-title":"No Title","volume":"55","author":"Waelsch","year":"1906","journal-title":"Deut Woch, M\u00fcnch Med Woch"},{"key":"10.1016\/j.urology.2019.01.001_bib0017","unstructured":"Lavenant, Zislin (Quoted by). No Title. These, Paris. 1911."},{"key":"10.1016\/j.urology.2019.01.001_bib0018","article-title":"No Title","volume":"275 and 588","author":"Pool","year":"1901","journal-title":"Jour Of Cut G-U Dis"},{"key":"10.1016\/j.urology.2019.01.001_bib0019","first-page":"53","article-title":"No Title","volume":"1","author":"Bernasconi","year":"1912","journal-title":"Rev Clin d'Urol, Paris"},{"key":"10.1016\/j.urology.2019.01.001_bib0020","article-title":"No Title","author":"LeFur","year":"1912","journal-title":"16th Sess l'Assoc Fr de l'Urol, Paris"},{"key":"10.1016\/j.urology.2019.01.001_bib0021","first-page":"612","article-title":"No Title","volume":"117","author":"Sonntag","year":"1921","journal-title":"Arch F Klin Chir"},{"key":"10.1016\/j.urology.2019.01.001_bib0022","first-page":"673","article-title":"No Title","volume":"75","author":"Kumer","year":"1922","journal-title":"Dermat Woch"},{"key":"10.1016\/j.urology.2019.01.001_bib0023","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0022-5347(17)70554-X","article-title":"Peyronie's disease, cause and treatment","volume":"49","author":"Wesson","year":"1943","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0024","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1749-6632.1949.tb55300.x","article-title":"The use of tocopherols in the treatment of Peyronie's disease","volume":"52","author":"Scardino","year":"1949","journal-title":"N Y Acad Sci"},{"key":"10.1016\/j.urology.2019.01.001_bib0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-5347(17)67832-7","article-title":"Peyronie's disease: a new approach","volume":"71","author":"Teasly","year":"1954","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0026","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-5347(17)67602-X","article-title":"Peyronie's disease: cortisone- hyaluronidase-hydrocortisone therapy","volume":"72","author":"Bodner","year":"1954","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000223891","article-title":"\u00dcber die Wirkung des oestrogen-hormontherapie bei der induratio penis plastica","volume":"8","author":"Minder","year":"1955","journal-title":"Oncologia"},{"key":"10.1016\/j.urology.2019.01.001_bib0028","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0022-5347(17)66108-1","article-title":"Treatment of Peyronie's disease with potassium para-amino benzoate (POTABA)","volume":"81","author":"Zarafonetis","year":"1959","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0029","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-5347(17)65809-9","article-title":"A new concept in the treatment of Peyronie's disease","volume":"83","author":"Whalen","year":"1960","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1464-410X.1963.tb02596.x","article-title":"Plastic induration of the penis: Peyronie's disease","volume":"35","author":"Chesney","year":"1963","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0031","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1464-410X.1967.tb09822.x","article-title":"Ultrasonic therapy in Peyronie's disease","volume":"39","author":"Heslop","year":"1967","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0032","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1749-6632.1967.tb34923.x","article-title":"The use of dimethyl sulfoxide in the treatment of genitourinary disorders","volume":"141","author":"Persky","year":"1967","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.urology.2019.01.001_bib0033","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-5347(17)63139-2","article-title":"The treatment of Peyronie's disease with iontophoresis of C21 esterified glucocorticoids","volume":"97","author":"Rothfeld","year":"1967","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0034","first-page":"499","article-title":"Traitement de l'induration plastique des corps caverneux par la procarbazine (Natulan)","volume":"76","author":"Aboulker","year":"1970","journal-title":"J Urol. (French)"},{"key":"10.1016\/j.urology.2019.01.001_bib0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-5347(17)67170-2","article-title":"The treatment of Peyronie's disease with parathyroid hormone","volume":"114","author":"Morales","year":"1975","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0036","first-page":"250","article-title":"Orgotein, a new drug for the treatment of Peyronie's disease","volume":"4","author":"Bartsch","year":"1981","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1016\/j.urology.2019.01.001_bib0037","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0022-5347(17)52339-3","article-title":"Topical beta-aminopropionitrile in the treatment of Peyronie's disease","volume":"129","author":"Gelbard","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0038","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","article-title":"Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0039","first-page":"107","article-title":"Laser therapy in Peyronie's disease","volume":"9","author":"Puente de la Vega","year":"1985","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.urology.2019.01.001_bib0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1464-410X.1988.tb05093.x","article-title":"Prostacyclin in the treatment of painful Peyronie's Disease","volume":"61","author":"Strachan","year":"1988","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0041","first-page":"417","article-title":"Possibility of using piezoelectric lithtryptor in the treatment of severe cavernous fibrosis","volume":"61","author":"Bellorofonte","year":"1989","journal-title":"Arch Ital Urol Nefrol Androl"},{"key":"10.1016\/j.urology.2019.01.001_bib0042","first-page":"1342","article-title":"Interferon \u03b12\u03b2 in the treatment of Peyronie's disease","volume":"61","author":"Benson","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0043","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.1992.tb15836.x","article-title":"The Treatment of Peyronie's disease with tamoxifen","volume":"70","author":"Ralph","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0044","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","article-title":"Intralesional verapamil injection for the treatment of Peyronie's disease","volume":"151","author":"Levine","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","article-title":"Is colchicine effective in Peyronie's disease? A pilot study","volume":"44","author":"Akkus","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urology.2019.01.001_bib0046","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1464-410x.2001.02241.x","article-title":"Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report","volume":"88","author":"Biagiotti","year":"2001","journal-title":"Br J U Int"},{"key":"10.1016\/j.urology.2019.01.001_bib0047","first-page":"S21","article-title":"Can an external penis strecher reduce Peyronie's penile curvature?","volume":"13","author":"Scroppo","year":"2001","journal-title":"Int J Imp Res"},{"key":"10.1016\/j.urology.2019.01.001_bib0048","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","article-title":"L-Arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures","volume":"9","author":"Valente","year":"2003","journal-title":"Nitric Oxide Biol Chem"},{"key":"10.1016\/j.urology.2019.01.001_bib0049","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ncpuro0409","article-title":"Treatment of Peyronie's disease with oral pentoxifylline","volume":"3","author":"Brant","year":"2006","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0050","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1743-6109.2009.01235.x","article-title":"Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: a prospective, randomized, double-blind placebo-controlled study","volume":"6","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2019.01.001_bib0051","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","article-title":"Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial","volume":"7","author":"Soh","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2019.01.001_bib0052","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ijir.2015.22","article-title":"Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study","volume":"28","author":"Twidwell","year":"2016","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2019.01.001_bib0053","first-page":"287","article-title":"Induratio penis plastica","author":"Polkey","year":"1928","journal-title":"Urol Cut Rev"},{"key":"10.1016\/j.urology.2019.01.001_bib0054","first-page":"1956","article-title":"Le traitement m\u00e9dical de la maladie de Dupuytren par un agent cytostatique (m\u00e9thylhydrazine)","volume":"76","author":"Aron","year":"1968","journal-title":"Presse M\u00e9dical"},{"key":"10.1016\/j.urology.2019.01.001_bib0055","first-page":"523","article-title":"R\u00e9sultats d'un traitement immunod\u00e9presseur dans la maladie de La Peyronie, la maladie de Dupuytren et certaines scl\u00e9rodermies","volume":"78","author":"Sturm","year":"1971","journal-title":"Bull de la Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Syphiligraphie"},{"key":"10.1016\/j.urology.2019.01.001_bib0056","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1464-410X.1975.tb03951.x","article-title":"Treatment of Peyronie's disease with procarbazine","volume":"47","author":"Oosterlinck","year":"1975","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0057","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00255956","article-title":"Collagenase for Peyronie's disease experimental studies","volume":"10","author":"Gelbard","year":"1982","journal-title":"Urol Res"},{"key":"10.1016\/j.urology.2019.01.001_bib0058","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijsu.2014.12.024","article-title":"Bromelain: a natural proteolytic for intra-abdominal adhesion prevention","volume":"14","author":"Sahbaz","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.urology.2019.01.001_bib0059","first-page":"1","article-title":"Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study","volume":"8","author":"Paulis","year":"2015","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.urology.2019.01.001_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BOR.0b013e32835b1352","article-title":"Myofibroblasts originate from locally present fibroblasts or from differentiated infiltrating fibrocytes or by local epithelial or endothelial cells","volume":"25","author":"Hu","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.urology.2019.01.001_bib0061","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.4253","article-title":"Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease","volume":"231","author":"Kramann","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.urology.2019.01.001_bib0062","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12681","article-title":"Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis","volume":"505","author":"Ding","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.urology.2019.01.001_bib0063","article-title":"Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urology.2019.01.001_bib0064","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/hmg\/ddt614","article-title":"Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype","volume":"23","author":"Watson","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.urology.2019.01.001_bib0065","first-page":"A8345","article-title":"Fibrosing disorders: insights into pathogenesis and new treatment options","volume":"159","author":"Dalm","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.urology.2019.01.001_bib0066","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2019.01.001_bib0067","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2019.01.001_bib0068","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/HYPERTENSIONAHA.113.01866","article-title":"Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension","volume":"63","author":"Jang","year":"2014","journal-title":"Hypertension"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951930010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951930010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T22:34:49Z","timestamp":1552430089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951930010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":68,"alternative-id":["S009042951930010X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2019.01.001","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Treatments of Peyronie's Disease: Past, Present, and Future","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}